Back to search
FDAFDA · Food and drugs·Recall number D-0009-2022

Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01

Published October 20, 2021 · Recall initiated: September 24, 2021

Summary

FDA records drug Class I recall D-0009-2022, published October 20, 2021 and initiated September 24, 2021. Recalling firm: Eli Lilly & Company; Status: Terminated; Reported quantity: 19,174 syringes; Lot: Lot #: D239382D, Exp. Date April 2022. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Eli Lilly & Company
Distributor
Nationwide with the USA and Puerto Rico; Canada, Argentina, Costa Rica, Mexico
Lot
Lot #: D239382D, Exp. Date April 2022
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01 recalled?

Yes. FDA published recall D-0009-2022 on October 20, 2021. Reported hazard: SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release